A Pitt faculty member is challenging the effectiveness of shared governance at Pitt, arguing the faculty senate has no real ...

The frontrunners in the COVID-19 vaccine race have emerged with different success rates for their shots in clinical trials, but what does that mean for the global fight against the pandemic?

Moderna Inc delivered the latest good news from COVID-19 vaccine developers, saying its experimental vaccine is 94.5% effective in preventing the disease based on interim data from a late-stage trial.

Introduction Hypertension constitutes the primary health burden of cardiovascular diseases, and the global control of blood pressure (BP) remains insufficient. Single pill combinations (SPCs) are ...

Background The long-acting monoclonal antibody nirsevimab and respiratory syncytial virus (RSV) vaccines became available for prevention of severe RSV-associated disease in 2023. While clinical trials ...

ABSTRACT: Introduction: Despite its proven efficacy, the use of fractional CO2 laser therapy is not without risks. Several complications and adverse effects may occur following its application.

Data captured from adult populations indicated BNT162b2 XBB.1.5-adapted and mRNA-1273 XBB.1.5-adapted monovalent vaccines conferred similar protection against XBB-related hospitalization, infection, ...

Purpose To determine the effects of advanced spectacle lens technologies on changes in spherical equivalent of refraction (SER) and axial length (AL) elongation in slowing down the progression of ...

For older adults, the vaccine against respiratory syncytial virus (RSV) appears to be most effective in the first year after administration, according to new research that shows the benefits of the ...

Department of Neurology and Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China Background: The effectiveness of Botulinum toxin type ...